TEL1 fundamentals
An in-depth look to Sihuan Pharmaceutical Holdings Group Ltd. operating, investing, and financing activities
TEL1 free cash flow for H2 23 is 26.51 M EUR. For 2023, TEL1 free cash flow was 23.12 M EUR and operating cash flow was 39.18 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM